Natalie Collins, MD, PhD
Physician, Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Assistant Professor of Pediatrics, Harvard Medical School
Image
Natalie Collins, MD, PhD
Physician, Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Assistant Professor of Pediatrics, Harvard Medical School
Medical Services
Languages
English
Education
Medical School
University of Virginia School of Medicine
2009
Charlottesville
VA
Internship
Boston Combined Residency Program (BCRP)
2010
Boston
MA
Residency
Pediatrics
Boston Combined Residency Program (BCRP)
2011
Boston
MA
Fellowship
Pediatric Hematology-Oncology
Dana-Farber/Boston Children's Cancer and Blood Disorders
2015
Boston
MA
Certifications
American Board of Pediatrics (General)
American Board of Pediatrics (Hematology-Oncology)
Publications
Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics. View Abstract
Author Correction: Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer. View Abstract
Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer. View Abstract
Off-label prescribing of immune checkpoint inhibitor therapy at a single pediatric cancer center. View Abstract
Early detection of malignant and pre-malignant peripheral nerve tumors using cell-free DNA fragmentomics. View Abstract
A spatial cell atlas of neuroblastoma reveals developmental, epigenetic and spatial axis of tumor heterogeneity. View Abstract
Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency. View Abstract
Learning About Mismatch Repair From a Rare Cancer Syndrome: A LOGICal Step Forward. View Abstract
Rare FGFR Oncogenic Alterations in Sequenced Pediatric Solid and Brain Tumors Suggest FGFR Is a Relevant Molecular Target in Childhood Cancer. View Abstract
Derivation and validation of a risk classification tree for patients with synovial sarcoma. View Abstract
PI3K activation allows immune evasion by promoting an inhibitory myeloid tumor microenvironment. View Abstract
Molecular Characterization of Inflammatory Tumors Facilitates Initiation of Effective Therapy. View Abstract
Author Correction: A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors. View Abstract
Role of Surgery in Rhabdomyosarcoma of the Head and Neck in Children. View Abstract
The use of interval-compressed chemotherapy with the addition of vincristine, irinotecan, and temozolomide for pediatric patients with newly diagnosed desmoplastic small round cell tumor. View Abstract
A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors. View Abstract
Genomic and Immunologic Characterization of INI1-Deficient Pediatric Cancers. View Abstract
Pediatric post-transplant hepatic kaposi sarcoma due to donor-derived human herpesvirus 8. View Abstract
Binding of FANCI-FANCD2 Complex to RNA and R-Loops Stimulates Robust FANCD2 Monoubiquitination. View Abstract
Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade. View Abstract
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target. View Abstract
PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity. View Abstract
Use of a fever fast track tool to reduce time to antibiotic dose in febrile pediatric oncology patients. View Abstract
ATR-dependent phosphorylation of FANCA on serine 1449 after DNA damage is important for FA pathway function. View Abstract